[1] |
Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description[J]. Circulation, 2002, 106(24):3006-3008.
doi: 10.1161/01.cir.0000047200.36165.b8
pmid: 12473543
|
[2] |
Mylotte D, Osnabrugge RLJ, Windecker S, et al. Transcatheter aortic valve replacement in Europe: Adoption trends and factors influencing device utilization[J]. J Am Coll Cardiol, 2013, 62(3):210-219.
doi: S0735-1097(13)01886-X
pmid: 23684674
|
[3] |
Alkhouli M, Alqahtani F, Ziada KM, et al. Contemporary trends in the management of aortic stenosis in the USA[J]. Eur Heart J, 2020, 41(8):921-928.
doi: 10.1093/eurheartj/ehz568
pmid: 31408096
|
[4] |
Lee HA, Chou AH, Wu VC, et al. Balloon-expandable versus self-expanding transcatheter aortic valve replacement for bioprosthetic dysfunction: A systematic review and meta-analysis[J]. PLoS One, 2020, 15(6):e0233894.
|
[5] |
Ali N, Hildick-Smith D, Parker J, et al. Long-term durability of self-expanding and balloon-expandable transcatheter aortic valve prostheses: UK TAVI registry[J]. Catheter Cardiovasc Interv, 2023, 101(5):932-942.
|
[6] |
Costa G, Saia F, Pilgrim T, et al. Transcatheter aortic valve replacement with the latest-iteration self-expanding or balloon-expandable valves: The multicenter OPERA-TAVI registry[J]. JACC Cardiovasc Interv, 2022, 15(23):2398-2407.
|
[7] |
Bhogal S, Waksman R, Shea C, et al. Self-expanding and balloon-expandable valves in low risk TAVR patients[J]. Int J Cardiol, 2024, 395:131431.
|
[8] |
Kalogeras K, Jabbour RJ, Pracon R, et al. Midterm outcomes in patients with aortic stenosis treated with contemporary balloon-expandable and self-expanding valves: Does valve size have an impact on outcome?[J]. J Am Heart Assoc, 2023, 12(11):e028038.
|
[9] |
Okuno T, Dangas GD, Hengstenberg C, et al. Two-year clinical outcomes after successful transcatheter aortic valve implantation with balloon-expandable versus self-expanding valves: A subanalysis of the GALILEO trial[J]. Catheter Cardiovasc Interv, 2022, 100(4):636-645.
|
[10] |
Ou-Yang WB, Wang W, Dong J, et al. Propensity-matched comparison of balloon-expandable and self-expanding valves for transcatheter aortic valve replacement in a Chinese population[J]. Ann Transl Med, 2022, 10(2):97.
|
[11] |
Paitazoglou C, Meincke F, Hanke T, et al. The ALSTER-TAVI All-comers registry: Procedural and 1-year clinical outcomes of balloon-expandable vs self-expanding contemporary TAVI valves[J]. J Invasive Cardiol, 2021, 33(5):E356-E364.
|
[12] |
Thiele H, Kurz T, Feistritzer HJ, et al. Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: The randomized SOLVE-TAVI trial[J]. Eur Heart J, 2020, 41(20):1890-1899.
doi: 10.1093/eurheartj/ehaa036
pmid: 32049283
|
[13] |
Lanz J, Kim WK, Walther T, et al. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: A randomised non-inferiority trial[J]. Lancet, 2019, 394(10209):1619-1628.
doi: S0140-6736(19)32220-2
pmid: 31570258
|
[14] |
Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart rhythm society[J]. Circulation, 2019, 140(8):e382-e482.
|
[15] |
van Rosendael PJ, Delgado V, Bax JJ. Pacemaker implantation rate after transcatheter aortic valve implantation with early and new-generation devices: A systematic review[J]. Eur Heart J, 2018, 39(21):2003-2013.
doi: 10.1093/eurheartj/ehx785
pmid: 29420704
|
[16] |
Fadahunsi OO, Olowoyeye A, Ukaigwe A, et al. Incidence, predictors, and outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement: Analysis from the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT registry[J]. JACC Cardiovasc Interv, 2016, 9(21):2189-2199.
|
[17] |
Siontis GC, Juni P, Pilgrim T, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosisundergoing TAVR: A meta-analysis[J]. J Am Coll Cardiol, 2014, 64(2):129-140.
doi: 10.1016/j.jacc.2014.04.033
pmid: 25011716
|
[18] |
Ledwoch J, Franke J, Gerckens U, et al. Incidence and predictors of permanent pacemaker implantation followingtranscatheter aortic valve implantation: Analysis from the German transcatheter aortic valve interventions registry[J]. Catheter Cardiovasc Interv, 2013, 82(4):E569-577.
|
[19] |
Kolte D, Khera S, Nazir S, et al. Trends in cerebral embolic protection device use and association with stroke following transcatheter aortic valve implantation[J]. Am J Cardiol, 2021, 152:106-112.
doi: 10.1016/j.amjcard.2021.04.038
pmid: 34147212
|
[20] |
谭冠昶, 李炜杰, 李捷, 等. 经导管主动脉瓣置换术过程中使用Sentinel脑保护装置的效果和安全性分析[J]. 中国介入心脏病学杂志, 2023, 31(10):741-746.
|
[21] |
Hagar A, Li Y, Wei X, et al. Incidence, predictors, and outcome of paraval vular leak after transcatheter aortic valve implantation[J]. J Interv Cardiol, 2020:8249497.
|
[22] |
Athappan G, Patvardhan E, Tuzcu EM, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replace ment: Meta-analysis and systematic review of literature[J]. J Am Coll Cardiol, 2013, 61(15):1585-1595.
doi: 10.1016/j.jacc.2013.01.047
pmid: 23500308
|
[23] |
Kowalewski M, Gozdek M, Rafa GM, et al. Transcathether aortic valve implantation with the new repositionable self-expandable Medtronic Evolut R vs. CoreValve system: Evidence on the beneft of a meta-analytical approach[J]. J Cardiovasc Med (Hagerstown), 2019, 20(4):226-236.
doi: 10.2459/JCM.0000000000000757
pmid: 30829877
|
[24] |
Ando T, Briasoulis A, Holmes AA, et al. Sapien 3 versus Sapien XT prosthetic valves in transcatheter aortic valve implantation: A meta-analysis[J]. Int J Cardiol, 2016, 220:472-478.
doi: 10.1016/j.ijcard.2016.06.159
pmid: 27390972
|
[25] |
Deharo P, Bisson A, Herbert J, et al. Impact of sapien 3 balloon-expandable versus evolut r self-expandable transcatheter aortic valve implantation in patients with aortic stenosis: Data from a nationwide analysis[J]. Circulation, 2020, 141(4):260-268.
doi: 10.1161/CIRCULATIONAHA.119.043971
pmid: 31736332
|